Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
30.84
-0.09 (-0.29%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $3.71 billion as of April 28, 2025. Its market cap has increased by 51.39% in one year.
Market Cap
3.71B
Enterprise Value
2.21B
1-Year Change
51.39%
Ranking
Category
Stock Price
$30.84
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $3.71B, an increase of 267.98%. That is a compound annual growth rate of 30.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 3.71B | 6.85% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 790.35B |
| UnitedHealth Group | 380.38B |
| Johnson & Johnson | 370.61B |
| AbbVie | 330.82B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 222.98B |
| AstraZeneca | 215.41B |
| Novartis AG | 211.71B |